WPA
ABBV icon

Wealth Preservation Advisors’s AbbVie ABBV Stock Holding History

Wealth Preservation Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-785
Closed -$171K – 92
2026
Q1 		$171K Sell
785
-735
-48% -$163K 0.14% 74
2025
Q4 		$347K Buy
1,520
+80
+6% +$18.2K 0.17% 62
2025
Q3 		$333K Buy
1,440
+709
+97% +$144K 0.19% 59
2025
Q2 		$136K Buy
731
+230
+46% +$42.7K 0.08% 109
2025
Q1 		$105K Buy
+501
New +$97.4K 0.08% 117

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealth Preservation Advisors's ABBV Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 785 shares — an estimated $171K sold.

Wealth Preservation Advisors first reported a position in ABBV in Q1 2025 and held it in 5 quarters. The position peaked at $347K in Q4 2025. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wealth Preservation Advisors reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Wealth Preservation Advisors sold 785 AbbVie shares in Q2 2026, an estimated $171K.
  • Wealth Preservation Advisors first reported a position in AbbVie in Q1 2025 and held it in 5 quarters.
  • Wealth Preservation Advisors's AbbVie position peaked at $347K in Q4 2025.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.